Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2006

01-05-2006 | Original Paper

Relation of Anthropometric Measurements to Ovarian Cancer Risk in a Population-based Case–control Study (United States)

Authors: Neeraja B. Peterson, Amy Trentham-Dietz, Polly A. Newcomb, Zhi Chen, Tebeb Gebretsadik, John M. Hampton, Meir J. Stampfer, Walter C. Willett, Kathleen M. Egan

Published in: Cancer Causes & Control | Issue 4/2006

Login to get access

Abstract

Objective

To examine the relationship between anthropometric measures and ovarian cancer by menopausal status.

Methods

We analyzed data from a population-based case–control study comprised of 700 incident cases of epithelial ovarian cancer and 5,943 population controls from Massachusetts and Wisconsin enrolled between 1993 and 2001. In a telephone interview, information was gathered on established ovarian cancer risk factors, as well as adult height and age-specific body weight. Logistic regression was used to estimate multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for body mass index (BMI) throughout life.

Results

Recent BMI had no significant association with ovarian cancer risk (P-trend 0.14 for continuous BMI), after adjustment for age and other ovarian cancer risk factors. However, a non-significant positive association (overall P-trend 0.08) was observed for BMI at age 20; the risk estimate comparing a body mass of >25 kg/m2 to the lowest quintile (≤18.88 kg/m2) was moderately but non-significantly elevated (OR 1.46; 95% CI 0.92, 2.31).

Conclusion

Results of this study suggest that maintenance of a lean body mass, particularly in early adult life, may decrease ovarian cancer risk.
Literature
1.
Jemal A, Murray T, Ward E et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30PubMed
2.
Anonymous (2002) Cancer incidence in five continents, vol VIII. IARC Sci Publ 1-781
3.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638CrossRefPubMed
4.
Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE (1979) “Incessant ovulation” and ovarian cancer. Lancet 2:170–173PubMed
5.
Cramer DW, Welch WR, Hutchison GB, Willett W, Scully RE (1984) Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 63:833–838PubMed
6.
Farrow DC, Weiss NS, Lyon JL, Daling JR (1989) Association of obesity and ovarian cancer in a case–control study. Am J Epidemiol 129:1300–1304PubMed
7.
Purdie D, Green A, Bain C et al. (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case–control study. Survey of Women’s Health Study Group. Int J Cancer 62:678–684PubMed
8.
Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:822–8PubMed
9.
Hoyo C, Berchuck A, Halabi S et al. (2005) Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control 16:955–963CrossRefPubMed
10.
Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433CrossRefPubMed
11.
Annegers JF, Strom H, Decker DG, Dockerty MB, O’Fallon WM (1979) Ovarian cancer: incidence and case–control study. Cancer 43:723–729PubMed
12.
Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248PubMed
13.
Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296CrossRefPubMed
14.
Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ (1989) A case–control study of epithelial ovarian cancer. Am J Obstet Gynecol 161:10–16PubMed
15.
Mink PJ, Folsom AR, Sellers TA, Kushi LH (1996) Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology 7:38–45PubMed
16.
Lukanova A, Toniolo P, Lundin E et al. (2002) Body mass index in relation to ovarian cancer: a multi-centre nested case–control study. Int J Cancer 99:603–608CrossRefPubMed
17.
Parazzini F, Moroni S, La Vecchia C, Negri E, dal Pino D, Bolis G (1997) Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 33:1634–1637CrossRefPubMed
18.
Kuper H, Cramer DW, Titus-Ernstoff L (2002) Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13:455–463CrossRefPubMed
19.
Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132PubMed
20.
Trentham-Dietz A, Newcomb PA, Storer BE et al. (1997) Body size and risk of breast cancer. Am J Epidemiol 145:1011–1019PubMed
21.
Huang Z, Hankinson SE, Colditz GA et al. (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411PubMed
22.
Morimoto LM, White E, Chen Z et al. (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13:741–751CrossRefPubMed
23.
Trentham-Dietz A, Newcomb PA, Egan KM et al. (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533–542CrossRefPubMed
24.
Breslow NE DNE (1980) Statistical methods in cancer research, vol 1. The analysis of case–control studies. International Agency for Research on Cancer
25.
Willett W (1998) Nutritional epidemiology. Oxford University Press, New York
26.
Michels KB, Greenland S, Rosner BA (1998) Does body mass index adequately capture the relation of body composition and body size to health outcomes? Am J Epidemiol 147:167–172PubMed
27.
Dal Maso L, Franceschi S, Negri E et al. (2002) Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 38:1769–1774CrossRefPubMed
28.
Jordan SJ, Webb PM, Green AC (2005) Height, age at menarche, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:2045–2048CrossRefPubMed
29.
Anderson JP, Ross JA, Folsom AR (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women’s Health Study. Cancer 100:1515–1521CrossRefPubMed
30.
Lubin F, Chetrit A, Freedman LS et al. (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113–120CrossRefPubMed
31.
Anonymous (2002) IARC working group on the evaluation of cancer-preventive strategies: weight control and physical activity. IARC Press, Lyon, France
32.
van den Brandt PA, Spiegelman D, Yaun SS et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514–527PubMed
33.
Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60:81–89PubMed
34.
35.
Key TJ, Appleby PN, Reeves GK et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226PubMed
36.
Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88:756–758PubMed
37.
Hankinson SE, Willett WC, Manson JE et al. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292–1299CrossRefPubMed
38.
Dale PO, Tanbo T, Vaaler S, Abyholm T (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58:487–491PubMed
39.
Wajchenberg BL, Marcondes JA, Mathor MB, Achando SS, Germak OA, Kirschner MA (1989) Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil Steril 51:535–537PubMed
40.
Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ (1997) All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res 232:277–286CrossRefPubMed
41.
Nestler JE (2000) Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 24(Suppl 2):S71–S73PubMed
42.
Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774–1786CrossRefPubMed
43.
Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM (2001) Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61:6768–6776PubMed
44.
Silva EG, Tornos C, Fritsche HA Jr et al. (1997) The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 10:879–883PubMed
45.
Slotman BJ, Rao BR (1989) Response to inhibition of androgen action of human ovarian cancer cells in vitro. Cancer Lett 45:213–220CrossRefPubMed
46.
Cardillo MR, Petrangeli E, Aliotta N et al. (1998) Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Clin Cancer Res 17:231–237PubMed
47.
Murphy A, Cropp CS, Smith BS, Burkman RT, Zacur HA (1990) Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women. Fertil Steril 53:35–39PubMed
48.
Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M (1991) Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum. Am J Obstet Gynecol 165:596–602PubMed
49.
van d V, Blankenstein MA, Kloosterboer HJ, Haspels AA, Thijssen JH (1990) Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 41:345–352
50.
Helzlsouer KJ, Alberg AJ, Gordon GB et al. (1995) Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274:1926–1930CrossRefPubMed
51.
Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88:554–559CrossRefPubMed
52.
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771–776CrossRefPubMed
53.
Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1184–1203PubMed
54.
Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128:740–748PubMed
55.
Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466– 473PubMed
56.
Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35:295–309CrossRefPubMed
57.
Stewart AW, Jackson RT, Ford MA, Beaglehole R (1987) Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol 125:122–126PubMed
58.
Stunkard AJ, Albaum JM (1981) The accuracy of self-reported weights. Am J Clin Nutr 34:1593–1599PubMed
59.
Lawlor DA, Bedford C, Taylor M, Ebrahim S (2002) Agreement between measured and self-reported weight in older women. Results from the British Women’s Heart and Health Study. Age Ageing 31:169–174CrossRefPubMed
60.
Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC (1995) The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 19:570–572PubMed
61.
Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6:61–66PubMed
62.
Villanueva EV (2001) The validity of self-reported weight in US adults: a population based cross-sectional study. BMC Public Health 1:11CrossRefPubMed
63.
Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989) The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13:441–453PubMed
64.
Kuskowska-Wolk A, Bergstrom R, Bostrom G (1992) Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord 16:1–9PubMed
Metadata
Title
Relation of Anthropometric Measurements to Ovarian Cancer Risk in a Population-based Case–control Study (United States)
Authors
Neeraja B. Peterson
Amy Trentham-Dietz
Polly A. Newcomb
Zhi Chen
Tebeb Gebretsadik
John M. Hampton
Meir J. Stampfer
Walter C. Willett
Kathleen M. Egan
Publication date
01-05-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0416-1

Other articles of this Issue 4/2006

Cancer Causes & Control 4/2006 Go to the issue

Special Section on Cancer and Rhythm

Light During Darkness and Cancer: Relationships in Circadian Photoreception and Tumor Biology

Original Paper

Age-specific Fluoride Exposure in Drinking Water and Osteosarcoma (United States)

Original Paper

Milk, Dairy Products and Cancer Risk (Italy)

Special Section on Cancer and Rhythm

Risk of Breast Cancer After Night- and Shift Work: Current Evidence and Ongoing Studies in Denmark

Special Section on Cancer and Rhythm

Biological Clocks and Shift Work: Circadian Dysregulation and Potential Long-term Effects

Special Section on Cancer and Rhythm

Why Life Oscillates – from a Topographical Towards a Functional Chronobiology
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits